1st Quarter - Report — LIFE TECHNOLOGIES CORPORATION for LIFE TECHNOLOGIES CORPORATION (2012)

Firm

LIFE TECHNOLOGIES CORPORATION

Client

LIFE TECHNOLOGIES CORPORATION

Income

—

Expenses

$150,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

S. 1599: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, 2012; Provisions regarding National Institutes of Health funding.

Lobbyist	Covered position, as disclosed
JANET LYNCH LAMBERT	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1599 (112th)

Law Enforcement/Crime/Criminal Justice LAW

H.R.988/S.517and revision not yet numbered: Katie Sepich Enhanced DNA Collection Act of 2011; All provisions of the bill.

Lobbyist	Covered position, as disclosed
JANET LYNCH LAMBERT	N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 988 (112th)

Medical/Disease Research/Clinical Labs MED

HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011; Provisions regarding lab developed tests. Draft guidance regarding Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Provisions regarding FDA regulation of certain diagnostics.

Lobbyist	Covered position, as disclosed
JANET LYNCH LAMBERT	N/A
AMY MUHLBERG	N/A

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3207 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.